No Detail Found!

Application of Newcastle Disease Virus in the Treatment of Human and Canine Mammary Cancer

Author(s)
Arlinda Flores Coleto Laboratory of Veterinary Pathology, Faculty of Veterinary Medicine, Federal University of Uberlandia,Mato Grosso Avenue, 3289 - Bloco 2S - Umuarama, Minas Gerais,Brazil
Belchiolina Beatriz Fonseca Genetics and Biochemistry, Federal University of Uberlandia,Umuarama, Minas Gerais,Brazil
Alessandra Aparecida Medeiros-Ronchi Laboratory of Veterinary Pathology, Faculty of Veterinary Medicine, Federal University of Uberlandia,Mato Grosso Avenue, 3289 - Bloco 2S - Umuarama, Minas Gerais,Brazil
Abstract
Breast cancer is the most prevalent form of tumor worldwide and the leading cause of cancer among women globally. Similarly, mammary tumors are also common in canines, with a majority of them unfortunately being malignant. While chemotherapy is one of the most frequently employed treatments, it often comes with significant side effects. Consequently, alternative therapies are under investigation, including oncolytic viruses. The Newcastle disease virus (NDV) stands out due to its capacity to selectively target and destroy tumor cells while preserving healthy tissue, as well as its ability to trigger a robust antitumor immune response. Numerous studies support the utilization of NDV in treating various cancer types, ranging from brain tumors to gastrointestinal tract neoplasms. Other researches have also yielded promising results in the treatment of mammary neoplasms. This review aims to compile information about NDV and its application in oncolytic virotherapy for the study and treatment of human breast cancer and canine mammary tumors, employing cell lines, animal models, and clinical trials.
Publication Details
Page(s) 547-554
Published Journal: Pakistan Veterinary Journal, Volume: 44, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Mammary Neoplasm Newcastle disease virus Oncology
References
Abd-Aziz N,Stanbridge EJ,Shafee N .2016 .Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53. J General Virol, 97 : 3174-3182.
Adelfinger M,Bessler S,Frentzen A .2015 .Preclinical testing oncolytic vaccinia virus strain glv-5b451 expressing an anti-vegf single-chain antibody for canine cancer therapy. Viruses, 7 : 4075-4092.
Ahmad U,Ahmed I,Keong YY .2015 .Inhibitory and apoptosisinducing effects of newcastle disease virus strain af2240 on mammary carcinoma cell line. , : .
Ahmed I,Ahmad U,Keong YY .2014 .Induction of nitric oxide and TNF-Α in Newcastle disease virus (NDV) AF2240 infected RAW 264.7 macrophages and their cytotoxic activity on MDA-MB-231 breast cancer cell line. J Cancer Sci & Therapy, 6 : 1.
Al-Shammari AM,Abdullah AH,Allami ZM .2019 .-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3- Phosphate Downregulation. Front Mol Biosci, 6 : 90.
Al-Shammari AM,Al-Mudhafr MA,Al-Grawi EDC .2022 .Newcastle disease virus suppresses angiogenesis in mammary adenocarcinoma models. Bulgarian J Vet Med., : .
Al-Ziaydi AG,Al-Shammari AM,Hamzah MI .2020 .Hexokinase inhibition using D Mannoheptulose enhances oncolytic Newcastle disease virus-mediated killing of breast cancer cells. Cancer Cell International, 20 : 1-10.
Amin ZM,Ani MAC,Tan SW .2019 .Evaluation of a recombinant Newcastle Disease virus expressing human IL12 against human breast cancer. Scientific Reports, 9 : .
Burke S,Shergold A,Elder MJ .2020 .Oncolytic Newcastle Disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro. Cancer Immunology. Immunotherapy, 69 : 1015-1027.
Cejalvo T,Perisé-Barrios Del Portillo I,Laborda E .2018 .Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy. Cancer Res, 78 : 4891.
Cekanova M and Rathore K .2014 .Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Design, Development and Therapy, 8 : 1911-1921.
Chambers P,Millar NS,Bingham RW .1986 .Molecular cloning of complementary DNA to newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein. J General Virol, 67 : 475-486.
Cuadrado-Castano S,Ayllon J,Mansour M .2015 .Enhancement of the proapoptotic properties of Newcastle disease virus promotes tumor remission in syngeneic murine cancer models. Molecular Cancer Therapeutics, 14 : 1247-1258.
Das A,Shafiuzama M,Tirumurugaan KG .2017 .Therapeutic potential of ndv-2k17 strain in canine mammary gland tumor. Int J Chemical Studies, 5 : 605-609.
Dimitrov KM,Ramey AM,Qiu X .2016 .Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus). Infection, Genetics and Evolution, 39 : 22-34.
Dortmans JC,Koch G,Rottier J .2011 .Virulence of Newcastle disease virus: what is known so far? Vet Res 42. , : .
Elankumaran S,Chavan V,Qiao D .2010 .Type I interferonsensitive recombinant Newcastle disease virus for oncolytic virotherapy. J Virol, 84 : 3835.
Elankumaran S,Rockemann D,Samal SK .2006 .Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspasedependent pathways of cell death. J Virol, 80 : 7522-7534.
Freeman AI,Zakay-Rones Z,Gomori JM .2006 .Phase I/II trial of intravenous NDV HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Therapy, 13 : 221-228.
Frey SE,Newman FK,Cruz J .2002 .Dose-related effects of smallpox vaccine. The New England J Med, 346 : 1275-80.
Ganar K,Das M,Sinha S .2014 .Newcastle disease virus: current status and our understanding. Vir Res, 184 : 71-81.
Gómez A,Sardón D,Cejalvo T .2020 .Biodistribution analysis of oncolytic adenoviruses in canine patient necropsy samples treated with cellular virotherapy. Molecular Therapy - Oncolytics, 18 : 525-534.
Hegde S,Karanikas V,Evers S .2016 .The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition. Clinical Cancer Res, 22 : 1865-1874.
Ilyinskaya GV,Mukhina EV,Soboleva AV .2018 .Oncolytic sendai virus therapy of canine mast cell tumors (a pilot study). Frontiers in Vet Sci, 5 : 16.
Iizuka K,Shoji K,Fujiyuki T .2020 .Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells. Res Vet Sci, 133 : 313-317.
Jamal MH,Ch'ng WC,Yusoff K .2012 .Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization. Cancer Cell International, 12 : .
Ji Y,Liu T,Jia Y .2017 .Two single mutations in the fusion protein of Newcastle disease virus confer hemagglutinin-neuraminidase independent fusion promotion and attenuate the pathogenicity in chickens. Virology, 509 : 146-151.
Jin K,Tao X,Fan Y .2021 .Crosstalk between oncolytic viruses and autophagy in cancer therapy. Biomedicine & Pharmacotherapy, 134 : .
Kalid M,Jahanshiri F,Omar AR .2010 .Gene expression profiling in apoptotic MCF-7 cells infected with Newcastle Disease virus. Global Veterinaria, 5 : 334-340.
Kalyanasundram J,Hamid A,Yusoff K .2018 .Newcastle disease virus strain AF2240 as an oncolytic virus: a review. Acta Tropica, 183 : 126-133.
Karcher J,Dyckhoff G,Beckhove P .2004 .Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells. Cancer Res, 64 : 8057-8061.
Keshavarz M,Nejad ASM,Esghaei M .2020 .Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis. Saudi J Biol Sci, 27 : 47-52.
King JN .2017 .Master of Science in Biomedical and Veterinary Sciences, Faculty of the Virginia Polytechnic Institute. , : .
Lam HY,Yeap SK,Rasoli M .2011 .Safety and clinical usage of Newcastle disease virus in cancer therapy. BioMed Research, : .
Lam HY,Yusoff K,Yeap SK .2014 .Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells. Int J Med Sci, 11 : 1240-1247.
Lamb RA,Parks GD,Knipe DM,Howley M .2007 .Paramyxoviridae: the viruses and their replication. In: Fields Virology (Fields BN, : 1449-1496.
Laurie SA,Bell JC,Atkins HL .2006 .A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization. Clinical Cancer Res, 12 : 2555-62.
Liu T,Zhang Y,Cao Y .2021 .Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses. Gene Therapy, 28 : 697-717.
MacNeill AL,Weishaar KM,Séguin B .2018 .Safety of an oncolytic myxoma virus in dogs with soft tissue sarcoma. Viruses, 10 : 398.
Mahalingam D,Fountzilas C,Moseley J .2017 .A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma. Cancer Chemother Pharmacol, 79 : 697-703.
Marelli G,Howells A,Lemoine NR .2018 .Oncolytic viral therapy and the Immune System: a double-edged sword against cancer. Frontiers in Immunology 9., : .
Martini V,D'avanzo F,Maggiora M .2020 .Oncolytic virotherapy: new weapon for breast cancer treatment. Ecancermedicalscience, 14 : 1-19.
Meyyappan N .2003 .Oncolytic effect of Newcastle disease virus on the MCF-7 and MDAMB-231 breast cancer cell lines. Universiti Putra Malaysia., : .
Molouki A,Peeters B .2017 .Rescue of recombinant Newcastle disease virus: current cloning strategies and RNA polymerase provision systems. Archives of Virology, 162 : 1-12.
Naik S,Galyon GD,Jenks NJ .2018 .Comparative oncology evaluation of intravenous recombinant oncolytic vesicular stomatitis virus therapy in spontaneous canine cancer. Mol Cancer Therapeutics, 17 : 316-326.
Nelson NJ .1999 .Scientific interest in Newcastle Disease virus is reviving. JNCI J Nat Cancer Institute, 91 : 1708-1710.
Nishiya AT,Massoco CO,Felizzola CR .2016 .Comparative aspects of canine melanoma. Vet Sci, 3 : .
Niu Z,Bai F,Sun T .2015 .Recombinant newcastle disease virus expressing IL15 demonstrates promising antitumor efficiency in melanoma model. Technology in Cancer Res & Treatment, 14 : 607-615.
Othman F,Ideris A,Motalleb G .2010 .Oncolytic effect of Newcastle Disease virus AF2240 strain on the MCF-7 breast cancer cell line. Yakhteh, 12 : 17-24.
Pecora AL,Rizvi N,Cohen GI .2002 .Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clinical Oncology, 20 : 2251-66.
Puff C,Krudewig C,Imbschweiler I .2009 .Influence of persistent canine distemper virus infection on expression of RECK, matrixmetalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82). The Vet J, 182 : 100-107.
Raihan J,Ahmad U,Yong YK .2019 .Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines. BMC Cancer, 19 : 315.
Ramamurthy N,Pathak DC,D'Silva AL .2021 .Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro. Res Vet Sci, 139 : 159-165.
Salas Y,Márquez A,Diaz D .2015 .Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem. PLOS ONE 10., : .
Sánchez D,Cesarman-Maus G,Amador-Molina A .2018 .Oncolytic viruses for canine cancer treatment. Cancers, 10 : 1.
Sánchez D,Pelayo R,Medina L .2016 .Newcastle Disease virus: potential therapeutic application for human and canine lymphoma. Viruses, 8 : .
Santos MR,Xavier LP,Pires RL .2021 .Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines. Vet Comparative Oncology, 19 : 593-601.
Sarver AL,Makielski KM,DePauw TA .2022 .Increased risk of cancer in dogs and humans: A consequence of recent extension of lifespan beyond evolutionarily determined limitations?. Aging Cancer, 3 : 3-19.
Schirrmacher V,Stücker W,Lulei M . .2015b. Long-term survival of a breast cancer patient with extensive liver metastases upon immune. virotherapy: a case report. Immunotherapy, 7 : 855-60.
Schirrmacher V,Van Gool V,Stuecker W .2019 .Breaking therapy resistance: an update on oncolytic Newcastle Disease virus for improvements of cancer therapy. Biomedicines, 7 : .
Shan P,Tang B,Xie S .2021 .NDV-D90 inhibits 17 β-estradiolmediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells. J Cellular Biochem, 122 : 3-15.
Shobana R,Samal SK,Elankumaran S .2013 .Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy. J Virol, 87 : 3792.
Singh P,Destito G,Schneemann A .2006 .Canine parvovirus-like particles, a novel nanomaterial for tumor targeting. J Nanobiotechnology, 13 : 2.
Sinkovics J .1957 .Studies on the biological characteristics of the newcastle disease virus (NDV) adapted to the brain of newborne mice. Archiv für die gesamte Virusforschung, 7 : 403-411.
Song H,Zhong L,He J .2019 .Application of Newcastle disease virus in the treatment of colorectal cancer. World J Clinical Cases, 7 : 2143-2154.
Stephens T .2019 .The use of chemotherapy to prolong the life of dogs suffering from cancer: the ethical dilemma. Animals (Basel), 9 : 441.
Wang J,Chen H,Dai S .2022 .Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunityJournal for ImmunoTherapy of Cancer. , : .
Wang SL,Lee JJ,Liao AT .2016 .Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma. The Canadian veterinary journal. La revue veterinaire Canadienne, 57 : 271-276.
.2020 .Cancer today. Data source: GLOBOCAN 2020, : .
.2020 .Cancer today. Data source: GLOBOCAN, : .
Yurchenko KS,Zhou P,Kovner AV .2018 .Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model. PLOS ONE 13., : .
Zhao H,Janke M,Fournier P .2008 .Recombinant Newcastle Disease virus expressing human interleukin-2 serves as a potential. , : .
0

Citations

0

Downloads

80

Views